Further, 6/8 post COVID-19 Ab− and 6/7 Ab+ had a CD8+ T cell response to S N- or C-terminal domain of SARS-CoV-2, whereas 6/8 of the post COVID-19 Ab− and 4/7 of the Ab+ had a CD8+ response to NCAP. Here, CD8A is linked to COVID-19.